Moderna shares slide after report of delay in COVID-19 vaccine trial
Moderna reiterated that its trial will begin this month, and that the company has worked with the National Institutes of Health for its study plan.
Follow us on GoogleFILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)ByREUTERSFollow us on Google
